Riskpilot← Back to searchSign inGet full accessBech-Larsen Psykiatri AB
ABIn liquidationOrg 5567910764Medical specialists activities · NACE 8622Est. 20090 employees
Revenue 2021
SEK 0
EBITDA margin
—
-19% vs 2020
Equity ratio
99.7%
Financial strength
Net profit 2021
SEK 226K
+10% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | -19% |
| Net profit | SEK 226K | +10% |
| Total assets | SEK 5,8M | +1% |
| Equity | SEK 5,8M | +1% |
| Employees | 0 | — |
Legal name
Bech-Larsen Psykiatri AB
Org number
5567910764
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 oktober 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva psykiatrisk öppenvård och därmed förenlig verksamhet. Bolaget ska förvalta värdepapper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −28 | −15 | −16 | −16 | −19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −28 | −15 | −16 | −16 | −19 |
| Net financials | 2 | 444 | 27 | 223 | 246 |
| Profit before tax | −27 | 428 | 10 | 208 | 227 |
| Tax | 9 | −0 | −2 | −2 | −1 |
| Net profit | −18 | 428 | 8 | 206 | 226 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 5 653 | 5 913 | 5 751 | 5 781 | 5 821 |
| Equity | 5 633 | 5 892 | 5 729 | 5 757 | 5 801 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 20 | 20 | 23 | 24 | 20 |
| Total debt | 20 | 20 | 23 | 24 | 20 |
EBITDA margin
-1900000.0%
This company
15.8%
Market median
-12025416% vs market
20172021
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20172021
Return on equity
3.9%
This company
18.4%
Market median
-79% vs market
20172021
Net profit margin
22600000.0%
This company
8.1%
Market median
+279012246% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LA Liquidator | Liquidator | 2022 |
RM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bech-Larsen Psykiatri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Agneta Bech-Larsen | Liquidator | 0 companies |
| Rickard Mats Yngve Julin | Audit | 0 companies |
| Bjarne Greger Bech-Larsen | Deputy Board Member | 0 companies |